Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ramiprilat

EU orphan designation number: EU/3/13/1117   
Active ingredient: Ramiprilat
Indication: Treatment of Stargardt’s disease
Sponsor: Iris Pharma
Les Nertières, allée Hector Pintus, F-06610 La Gaude, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/03/2013 Centralised Orphan - Designation EMA/OD/175/12 (2013)1611 of 12/03/2013